Lanqi Gong

1.2k total citations · 1 hit paper
17 papers, 540 citations indexed

About

Lanqi Gong is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lanqi Gong has authored 17 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Lanqi Gong's work include RNA modifications and cancer (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Epigenetics and DNA Methylation (4 papers). Lanqi Gong is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Epigenetics and DNA Methylation (4 papers). Lanqi Gong collaborates with scholars based in Hong Kong, China and United States. Lanqi Gong's co-authors include Xin‐Yuan Guan, Yu Zhang, Xiaona Fang, Beilei Liu, Qian Yan, Dora Lai‐Wan Kwong, Ying Tang, Zhaojie Lyu, Ngar‐Woon Kam and Ching Ngar Wong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Cancer Research.

In The Last Decade

Lanqi Gong

16 papers receiving 538 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma

2024 54 citations Jiao Huang, Xiaona Fang et al. Cancer Research profile →

Peers

Lanqi Gong

ONCOL

IMMUN

EPIDE

Chunhui Zhou China

Rekha Samuel United States

Miran Rada Canada

Xiangrui Ma China

Candice Alexandra Grzelak United States

Alice Cani Italy

Radosław Szmyd Singapore

Lotte Hiddingh United States

Qiongdan Zheng China

Chunhui Zhou China

Lanqi Gong

294 ×1.1

158 ×1.0

ONCOL

176 ×1.2

121 ×0.9

IMMUN

38 ×0.6

EPIDE

Citations per year, relative to Lanqi Gong Lanqi Gong (= 1×) peers Chunhui Zhou

Countries citing papers authored by Lanqi Gong

Since Specialization

Citations

This map shows the geographic impact of Lanqi Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanqi Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanqi Gong more than expected).

Fields of papers citing papers by Lanqi Gong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanqi Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanqi Gong. The network helps show where Lanqi Gong may publish in the future.

Co-authorship network of co-authors of Lanqi Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Lanqi Gong. A scholar is included among the top collaborators of Lanqi Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lanqi Gong. Lanqi Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Liu, Qin, Jie Luo, Shanshan Li, et al.. (2025). SOX4-ZIP14-zinc metabolism mediates oncogenesis and suppresses T cell immunity in nasopharyngeal carcinoma. Cell Reports Medicine. 6(9). 102300–102300.

Luo, Min, Wenfu Lu, Baifeng Zhang, et al.. (2025). C1q⁺ Macrophage–Tumor Cell Interaction Promoted Tumorigenesis via GPR17/PI3K/AKT Pathway Induced DNA Hypermethylation in Nasopharyngeal Carcinoma. Advanced Science. 12(26). e2503434–e2503434. 1 indexed citations

Li, Shanshan, Baifeng Zhang, Yuying Fu, et al.. (2025). FAO-fueled OXPHOS and NRF2-mediated stress resilience in MICs drive lymph node metastasis. Proceedings of the National Academy of Sciences. 122(15). e2411241122–e2411241122. 5 indexed citations

Huang, Jiao, Xiaona Fang, Yu Zhang, et al.. (2024). FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma. Cancer Research. 84(6). 855–871. 54 indexed citations breakdown →

Gong, Lanqi, Dora Lai‐Wan Kwong, Victor Lee, et al.. (2023). Functions of double‐negative B cells in autoimmune diseases, infections, and cancers. EMBO Molecular Medicine. 15(9). e17341–e17341. 30 indexed citations

Liu, Beilei, Baifeng Zhang, Hongyu Zhou, et al.. (2023). Targeting MFGE8 secreted by cancer-associated fibroblasts blocks angiogenesis and metastasis in esophageal squamous cell carcinoma. Proceedings of the National Academy of Sciences. 120(42). e2307914120–e2307914120. 24 indexed citations

Liu, Beilei, Xiaona Fang, Dora Lai‐Wan Kwong, et al.. (2022). Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 41(1). 182–182. 27 indexed citations

Zhang, Yu, Douglas C. Palmer, Rigel J. Kishton, et al.. (2022). A T cell resilience model associated with response to immunotherapy in multiple tumor types. Nature Medicine. 28(7). 1421–1431. 40 indexed citations

Gong, Lanqi, et al.. (2022). GLIPR1 promotes proliferation, metastasis and 5-fluorouracil resistance in hepatocellular carcinoma by activating the PI3K/PDK1/ROCK1 pathway. Cancer Gene Therapy. 29(11). 1720–1730. 8 indexed citations

10.

Gong, Lanqi, Yu Zhang, Qian Yan, et al.. (2022). Inhibition of lysyl oxidase‐like 2 overcomes adhesion‐dependent drug resistance in the collagen‐enriched liver cancer microenvironment. Hepatology Communications. 6(11). 3194–3211. 15 indexed citations

11.

Yu, Liang, Qian Yan, Lanqi Gong, et al.. (2021). Correction: C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism. Oncogene. 40(35). 5451–5453. 6 indexed citations

12.

Gong, Lanqi, Dora Lai‐Wan Kwong, Wei Dai, et al.. (2021). The Stromal and Immune Landscape of Nasopharyngeal Carcinoma and Its Implications for Precision Medicine Targeting the Tumor Microenvironment. Frontiers in Oncology. 11. 744889–744889. 26 indexed citations

13.

Zhang, Yu, Qian Yan, Lanqi Gong, et al.. (2020). C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism. Oncogene. 40(6). 1147–1161. 72 indexed citations

14.

Wang, Ying, Zhaojie Lyu, Yanru Qin, et al.. (2020). FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma. Theranostics. 10(25). 11535–11548. 111 indexed citations

15.

Zhang, Jinliang, Lanqi Gong, Qian Yan, et al.. (2019). Advances in surface markers of liver cancer stem cell. Hepatoma Research. 2019. 8 indexed citations

16.

Gong, Lanqi, Qian Yan, Yu Zhang, et al.. (2019). Cancer cell reprogramming: a promising therapy converting malignancy to benignity. Cancer Communications. 39(1). 48–48. 55 indexed citations

17.

Qian, Weiyi, Lanqi Gong, Xin Cui, et al.. (2017). Nanotopographic Regulation of Human Mesenchymal Stem Cell Osteogenesis. ACS Applied Materials & Interfaces. 9(48). 41794–41806. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact